2-Bromo-4,5-methylenedioxyamphetamine
Appearance
This article relies largely or entirely on a single source. (September 2019) |
Names | |
---|---|
IUPAC name
2-(6-Bromobenzo[1,3]dioxol-5-yl)-1-methylethylamine
| |
Other names
2-Bromo-4,5-methylenedioxyamphetamine
2-(2-Bromo-4,5-methylenedioxyphenyl)ethan-1-methyl-amine | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C11H17BrNO2 | |
Molar mass | 275.166 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
2-Bromo-4,5-methylenedioxyamphetamine (6-Bromo-MDA) is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dose is listed as 350 mg and the duration unknown.[1] It produces stimulant effects but with no psychedelic or empathogenic action.[1] Very little data exists about its pharmacological properties, metabolism, and toxicity.
See also
References